Related news
Discover more stories about Mitacs — and the game-changing innovations driven by students and postdocs.
Toronto, ON – Mitacs, a national innovation connector that supports business-academic research collaboration, and Ontario Genomics, a not-for-profit organization that leads the commercialization of genomics-based solutions across key sectors of the economy, have announced a new Memorandum of Understanding (MOU) to collaborate on strategic initiatives.
Through this agreement, Mitacs and Ontario Genomics will deepen collaboration to accelerate research, talent development, and commercialization across Ontario genomics and biotech sectors. This collaboration strengthens both organizations’ shared commitment to advancing innovation and delivering real-world solutions that support Canada’s economic growth and competitiveness.
Key areas of collaboration include:
- Strategic initiatives: Jointly exploring scalable pilot projects and expanding opportunities for Mitacs internships within Ontario Genomics programs, including the BioCreate business accelerator and GAPP research commercialization program.
- Thought leadership and ecosystem development: Engaging in joint discussions and events to advance communications, knowledge sharing, and strengthen Ontario’s innovation landscape.
- Network alignment: Enhancing referral pathways and coordinated support for companies, researchers, and trainees across both organizations.
Quotes
“Mitacs and Ontario Genomics share a strong commitment to advancing Ontario’s genomics ecosystem. By creating networks that connect researchers to industry and start-ups, we are accelerating R&D and building innovation capacity for strengthening Canadian economic growth, productivity, and competitiveness.”
— Dr. Stephen Lucas, CEO, Mitacs
“Ontario Genomics is focused more than ever on getting products and technologies out of the lab and into our everyday lives. This partnership with Mitacs can create real world impacts in food and agriculture, health, and cleantech by offering the people behind these innovations the kind of support they need to tangibly contribute to Canada’s economic diversification.”
— John Rafferty, CEO, Ontario Genomics
About Mitacs
For over 25 years, Mitacs has helped grow the economy and develop the workforce of tomorrow, connecting industry with academia and global partners to solve real-world challenges. We support business-academic research collaboration through internships, co-funded with businesses, for undergraduate to graduate students and post-doctoral fellows.
As a national innovation connector, Mitacs takes a talent-first approach to strengthen innovation capacity and drive global competitiveness. We serve as an essential research-commercialization bridge, accelerating market entry and growth for new products and services.
This is a critical time for Canada to think big and take bold action. Mitacs is ready to help build a strong and resilient Canadian economy, powered by ideas, talent and innovation.
Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.
About Ontario Genomics
Ontario Genomics invests in researchers and start-ups to drive industrial biotech commercialization through homegrown, cutting-edge solutions in food and agriculture, medicine and cleantech. With more than 600 partnerships and $3.5 billion in investments, we’ve been working with governments, industry and innovators for over 25 years to get ideas out of the lab and into the real world. Learn more at OntarioGenomics.ca.
